[1. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010; 69(2): 312-325.10.1136/ard.2009.11369619773290]Search in Google Scholar
[2. Martin-Martinez MA, Gonzalez-Juanatey C, Castaneda S, Llorca J, et al. Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion. Semin Arthritis Rheum. 2014; 44(1): 1-8.10.1016/j.semarthrit.2014.01.00224560170]Search in Google Scholar
[3. Borman P, Taşbaş O, Karabulut H, Tukun A, Yorgancıoğlu R. Thymidylate synthase genetic polymorphism and plasma total homocysteine level in a group of Turkish patients with rheumatoid arthritis: relationship with disease activity and methotrexate toxicity. Rev Bras Reumatol. 2015. pii: S0482-5004(15)00017-0. doi: 10.1016/j.rbr.2014.12.001.10.1016/j.rbr.2014.12.00125687398]Search in Google Scholar
[4. Selhub J. The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr. 2006; 136(6): 1726-1730.10.1093/jn/136.6.1726S16702347]Search in Google Scholar
[5. Sarwar AB, Sarwar A, Rosen BD, Nasir K. Measuring subclinical atherosclerosis: is homocysteine relevant? Clin Chem Lab Med. 2007; 45(12): 1667-1677.10.1515/CCLM.2007.34917990951]Search in Google Scholar
[6. Baskan BM, Sivas F, Aktekin LA, Dogan YP, Ozoran K, Bodur H. Serum homocysteine level in patients with ankylosing spondylitis. Rheumatol Int. 2009; 29(12): 1435-1439.10.1007/s00296-009-0875-x19288264]Search in Google Scholar
[7. Choi ST, Kim JS, Song JS. Elevated serum homocysteine levels were not correlated with serum uric acid levels, but with decreased renal function in gouty patients. Korean Med Sci. 2014; 29(6): 788-792.10.3346/jkms.2014.29.6.788405581124932079]Search in Google Scholar
[8. Caramaschi P, Martinelli N, Biasi D, Carletto A, Faccini G, Volpe A, et al. Homocysteine plasma concentration is related to severity of lung impairment in scleroderma. J Rheumatol. 2003; 30(2): 298-304.]Search in Google Scholar
[9. Perna M1, Roman MJ, Alpert DR, Crow MK et al. Relationship of asymmetric dimethylarginine andhomocysteine to vascular aging in systemic lupus erythematosus patients. Arthritis Rheum. 2010; 62(6): 1718-1722.10.1002/art.2739220155836]Search in Google Scholar
[10. Jednacz E, Rutkowska-Sak L. Atherosclerosis in juvenile idiopathic arthritis. Mediators Inflamm. 2012; 2012: 714732.10.1155/2012/714732342586822933832]Search in Google Scholar
[11. Slot O. Homocysteine, a marker of cardiovascular disease risk, is markedly elevated in patients with gout. Ann Rheum Dis. 2013; 72(3): 457.10.1136/annrheumdis-2012-20202322887852]Search in Google Scholar
[12. Aletaha D, Neogi T, SIlman A, Funovits J, Felson DT et al. 2010 rheumatoid arthritis classification criteria: an America college of rhuematology/European League against Rheumatism collaborative initiative. Ann Rheum Dis. 2010; 69: 1580–1588.10.1136/ard.2010.13846120699241]Search in Google Scholar
[13. Prevoo ML, van’t Hof MA, Kuper HH et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995; 38: 44–48.10.1002/art.17803801077818570]Search in Google Scholar
[14. Van Ede AE, Laan RF, Blom HJ et al. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology. 2002; 41(6): 658-665.10.1093/rheumatology/41.6.65812048292]Search in Google Scholar
[15. Kayacelebi AA, Willers J, Pham VV et al. Plasma homoarginine, arginine, asymmetric dimethylarginine and total homocysteine interrelationships in rheumatoid arthritis, coronary artery disease and peripheral artery occlusion disease. Amino Acids. 2015 Jan 25. [Epub ahead of print].10.1007/s00726-015-1915-325618752]Search in Google Scholar
[16. Willers J, Hahn A. Cardiovascular risk in patients with risk parameters and a German risk score model. Rheumatol Int. 2012; 32(12): 3741-3749.10.1007/s00296-011-2238-722147110]Search in Google Scholar
[17. Rezuş E, Floria M, Grigoriu A, Tamba BI, Rezus C. Cardiovascular Risk Factors In Chronic Inflammatory Rheumatic Diseases: Modern Assessment And Diagnosis. Curr Vasc Pharmacol. 2015 Jan 4. [Epub ahead of print].10.2174/157016111366615010511282025563857]Search in Google Scholar
[18. Szekanecz Z, Kerekes G, Der H, Sandor Z et al. Accelerated atherosclerosis in rheumatoid arthritis. Ann N Y Acad Sci. 2007; 1108: 349-358. 19. Goodson NJ, Symmons DP, Scott DG, Bunn D, Lunt M, Silman AJ. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis and Rheumatism. 2005; 52(8): 2293–2299.10.1002/art.2120416052597]Search in Google Scholar
[20. Gonzalez-Gay MA, Gonzalez-Juanatey C, Pineiro A, Garcia-Porrua C, Testa A, Llorca J. High-grade Creactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatology. 2005; 32(7): 1219–1223.]Search in Google Scholar
[21. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2007; 57(1): 125-132.10.1002/art.2248217266100]Search in Google Scholar
[22. Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, et al. A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis. Arthritis Res Ther. 2010; 12(2): R71.10.1186/ar2989288822720423475]Search in Google Scholar
[23. Nowakowska-Plaza A, Potaczek DP, Gluszko P, Undas A. Antibodies to N-homocysteinylated albumin and haemoglobin in patients with rheumatoid arthritis: a 2014; 43(1): 17-21.]Search in Google Scholar
[24. Woolf K, Manore MM. Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis. J Am Diet Assoc. 2008; 108(3): 443-453.10.1016/j.jada.2007.12.00118313425]Search in Google Scholar
[25. van Ede AE, Laan RF, Blom HJ, Boers GH et al. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology. 2002; 41(6): 658-665.10.1093/rheumatology/41.6.65812048292]Search in Google Scholar
[26. Galiutina OIu, Bychak OV. Relationship of silent myocardial ischiemia with the course of rheumatoid arthritis and hyperhomocysteinemia. Lik Sprava. 2011; (1-2): 48-52.]Search in Google Scholar